Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 64M P/E - EPS this Y - Ern Qtrly Grth -
Income -24.2M Forward P/E -2.42 EPS next Y - 50D Avg Chg -3.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -1.00%
Dividend N/A Price/Book 1.67 EPS next 5Y - 52W High Chg -80.00%
Recommedations 2.00 Quick Ratio 4.31 Shares Outstanding 55.26M 52W Low Chg 67.00%
Insider Own 45.32% ROA -29.29% Shares Float 30.08M Beta 3.61
Inst Own 10.31% ROE -86.10% Shares Shorted/Prior 866.33K/834.23K Price 1.26
Gross Margin - Profit Margin - Avg. Volume 42,709 Target Price -
Oper. Margin - Earnings Date Nov 12 Volume 26,008 Change 0.80%
About Vivani Medical, Inc.

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.

Vivani Medical, Inc. News
11/16/24 Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 30% More Shares
11/13/24 Vivani Medical: Q3 Earnings Snapshot
11/13/24 Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
10/29/24 Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
10/22/24 3 US Penny Stocks To Monitor In October 2024
10/22/24 Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024
09/27/24 Vivani Medical obtains Australian approval to begin GLP-1 implant trial
09/26/24 Vivani Medical to Test Implant in Obese and Overweight Patients
09/26/24 Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
09/26/24 EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
09/24/24 Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
09/23/24 Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024
09/04/24 Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant
09/04/24 EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
08/28/24 Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
08/14/24 Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation
08/13/24 Vivani Medical: Q2 Earnings Snapshot
08/13/24 Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
07/12/24 Vivani to start in-human trial for GLP-1 implant for treating obesity
07/11/24 Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115
VANI Chatroom

User Image BriamG316 Posted - 6 hours ago

"Vivani Medical’s commitment to improving lives is inspiring! Their innovative approach to restoring vision for those suffering from retinal diseases is truly game-changing. As they move closer to FDA approval, $VANI could be poised for incredible growth! 👀💡 #InvestInInnovation #VANI"

User Image aegslwdc Posted - 23 hours ago

Any thoughts from anyone regarding how the Cortigent IPO will influence the near term trading of $VANI?

User Image ballyhooo Posted - 1 day ago

$VANI *Vivani Medical Unit Cortigent Expects IPO of 1.5M Shrs to Price at $10 Each

User Image BriamG316 Posted - 1 day ago

"Exciting news in the medical tech space! 🚀 Vivani Medical is at the forefront of advancing biotechnologies with their promising implantable retinal device. With clinical trials progressing and groundbreaking technology, this company is one to watch! 🔥 $VANI $FBRX $XCUR #Biotech"

User Image Icre8miraco Posted - 2 days ago

$VANI looking good holding welll yesterday so far

User Image ZabDad Posted - 2 days ago

$VANI If I was an insider and during weekly office convo I was advised that product testing/results thus far is very promising, I’d buy $5,000,000 in stock at this price, too.

User Image trader2360 Posted - 3 days ago

$VANI good bye... insiders are buying.

User Image Stocksprofessional Posted - 3 days ago

$VANI Added more. This is a solid company with a robust pipeline, and insiders are buying aggressively. Always swim with the current—when insiders put their money where their mouth is, it’s a strong signal of confidence in their company and its products. Their belief in NanoPortal as a potential blockbuster in drug delivery, alongside AI, is particularly compelling. Mark this post.

User Image Stocksprofessional Posted - 3 days ago

$VANI wake me up when it hits $28. Long and strong

User Image annee33 Posted - 1 week ago

$VANI has a heartbeat, volume coming in

User Image Stocksprofessional Posted - 1 week ago

$VANI 📈

User Image PLATINUM_TRADES Posted - 1 week ago

$VANI nice day today but we keeping it.. Break $1.50 this can take a nice trip.... 🏆 🏆 🏆

User Image TrendsetterTrading Posted - 1 week ago

$VANI watch for consolidation under resistance followed by a $1.40 price breakout

User Image Durand32 Posted - 1 week ago

$VANI Now they need a follow up PR saying they have completed enrollment and are about to start the clinical study for the GLP-1 implants. There are only 6 weeks left in the 4th Q so it should be starting soon.

User Image annee33 Posted - 1 week ago

$VANI broke out with Volume

User Image tsapa Posted - 1 week ago

$VANI Couple thoughts. First, why would Gregg Williams purchase roughly $5 million in stock while Vivani simulataneouly announced a $5 million common stock offering? Am I missing something? Shouldn't they have announced the price per stock under the new offering? Second, I'm assuming/more hoping that Vivani is drawing licensing/merger interest from BIG PHARMA after the recent conferences, and that's why Gregg made a move. But if that was the case, why would they bother doing a stock offering and diluting their value. Tomorrow should be interesting....

User Image Tanestein Posted - 1 week ago

$VANI Strong buy & Long term hold. Setting up for a nice breakout..

User Image Stocksprofessional Posted - 1 week ago

$VANI Prior to this transaction, the insider held a substantial 45.32% ownership stake in the company. Furthermore, one of the directors acquired a significant number of shares in Vivan, totaling 3,968,253 shares. The saying, “Put your money where your mouth is,” seems particularly fitting here, as this move reflects strong confidence from every angle. Insiders clearly believe in the company’s pipeline and see considerable potential for future growth.

User Image ZabDad Posted - 1 week ago

$VANI Mr. Williams feels strongly about the success of the company. And… According to TipRanks, the average 12-month price target for Vivani Medical (VANI) is $8.00. This target is based on analyst ratings and gives VANI a 501.50% upside potential.

User Image AZOZ Posted - 1 week ago

$VANI insider's love it right now!

User Image builderup Posted - 1 week ago

New positions (Swing) $NRXP $CARM $VANI Keep these on your radar!

User Image Ahaeck Posted - 1 week ago

$VANI https://m.investing.com/news/insider-trading-news/vivani-medical-director-gregg-williams-buys-5-million-in-stock-93CH-3720075?ampMode=1

User Image ballyhooo Posted - 1 week ago

$VANI Regulatory approval to initiate first-in-human study with a miniature, ultra long-acting GLP-1 (exenatide) implant in obese or overweight individuals in Australia Miniature, ultra long-acting GLP-1 implant produced sham-implant adjusted liver fat reduction of 82% in an obese mouse model from a single administration with expected twice-yearly dosing Announces $5M equity financing which secures solid financial position into late 2025, supporting projected completion of first-in-human study and data read-out .

User Image Joesh82 Posted - 1 week ago

$VANI "Vivani Medical Director Gregg Williams Acquires Over 3.9 Million Shares" purchase price $1.26 on Nov 8th for a total of $5m

User Image builderup Posted - 1 week ago

$NRXP taking a position. $VANI 👀👀👀

User Image builderup Posted - 1 week ago

$VANI on deck. 👀👀👀.

User Image Stocksprofessional Posted - 2 weeks ago

$VANI Patience is key. Whatever they’re planning, they can’t keep the stock down forever. It seems they’re holding it back to buy more from weaker sellers, maybe because they see potential or expect a buyout soon. Vani’s NanoPortal technology could be used for drug implants to treat chronic diseases and improve medication adherence, with a focus on high-demand areas like obesity and diabetes. If approved, it could be applied to various drugs. For me, it doesn’t make sense to sell a single share under $28 as a first target after phase 1. I’m confident it will reach that level sooner or later.

User Image Earl40 Posted - 2 weeks ago

$VANI Is heavily manipulated. No matter how good of news that comes out. Selfish motherfuckers keeps this stock down. Probably some other drug company is trying to surpress this stock and its products...

User Image ballyhooo Posted - 2 weeks ago

$VANI --HC Wainwright Starts Vivani Medical With Buy Rating, $3 Price Target

User Image ACInvestorBlog Posted - 2 weeks ago

HC Wainwright initiated $VANI coverage with BUY rating and $3 price target

Analyst Ratings
ThinkEquity Buy Dec 5, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Williams Gregg Director Director Feb 05 Buy 1.01 1,995 2,015 724,340 02/06/24
Williams Gregg Director Director Jan 31 Buy 1.01 100 101 722,345 02/02/24
Williams Gregg Director Director Jan 23 Buy 1.01 834 842 722,245 01/25/24
Williams Gregg Director Director Jan 22 Buy 1.01 7,620 7,696 721,411 01/22/24
Williams Gregg Director Director Jan 18 Buy 1.01 1,076 1,087 713,791 01/19/24
Williams Gregg Director Director Jan 16 Buy 1.01 13,067 13,198 712,715 01/16/24
Williams Gregg Director Director Jan 08 Buy 1.08 6,731 7,269 699,648 01/09/24
Williams Gregg Director Director Jan 04 Buy 1.08 6,200 6,696 692,917 01/05/24
Williams Gregg Director Director Jan 02 Buy 1.01 7,111 7,182 686,717 01/03/24
Williams Gregg Director Director Dec 22 Buy 1.00 100 100 679,606 12/27/23
Williams Gregg Director Director Dec 19 Buy 0.87 153,872 133,869 679,506 12/21/23
Williams Gregg Director Director Dec 14 Buy 0.89 4,301 3,828 525,634 12/18/23
Makes Brigid CFO CFO Dec 15 Buy 0.88 5,000 4,400 15,000 12/18/23
Williams Gregg Director Director Dec 11 Buy 0.88 29,806 26,229 521,333 12/13/23
Williams Gregg Director Director Dec 06 Buy 0.96 993 953 491,527 12/08/23
Williams Gregg Director Director Nov 22 Buy 0.95 3,463 3,290 490,534 11/27/23
Dwyer Donald Chief Business Offic.. Chief Business Officer Nov 20 Buy 0.96 5,500 5,280 36,500 11/22/23
Williams Gregg Director Director Nov 16 Buy 0.95 3,266 3,103 487,071 11/20/23
Williams Gregg Director Director Oct 20 Buy 1 103,368 103,368 483,805 10/24/23
Williams Gregg Director Director Oct 12 Buy 1 12,419 12,419 380,437 10/16/23
Williams Gregg Director Director Oct 09 Buy 1.00 664 664 368,018 10/11/23
Williams Gregg Director Director Oct 06 Buy 1.02 87,887 89,645 367,354 10/10/23
Williams Gregg Director Director Oct 03 Buy 1 9,924 9,924 279,467 10/05/23
Williams Gregg Director Director Sep 28 Buy 1.02 36,210 36,934 269,543 10/02/23
Dwyer Donald Chief Business Offic.. Chief Business Officer Sep 27 Buy 1.01 1,000 1,010 31,000 09/27/23
Williams Gregg Director Director Sep 25 Buy 0.96 26,681 25,614 233,333 09/27/23
Williams Gregg Director Director Sep 20 Buy 0.93 21,426 19,926 206,652 09/22/23
Williams Gregg Director Director Sep 14 Buy 0.96 101,779 97,708 185,226 09/18/23
Williams Gregg Director Director Sep 08 Buy 0.95 13,997 13,297 83,447 09/12/23
Williams Gregg Director Director Sep 05 Buy 0.94 53,267 50,071 69,450 09/07/23
Dwyer Donald Chief Business Offic.. Chief Business Officer Aug 31 Buy 0.94 7,500 7,050 30,000 09/05/23
Makes Brigid CFO CFO Aug 31 Buy 0.92 6,000 5,520 10,000 09/05/23
Williams Gregg Director Director Aug 31 Buy 0.93 16,183 15,050 16,183 09/01/23
Makes Brigid CFO CFO Jun 27 Buy 1.23 4,000 4,920 4,000 06/29/23
Dwyer Donald Chief Business Offic.. Chief Business Officer Jun 22 Buy 1.24 5,000 6,200 15,000 06/26/23
Mendelsohn Aaron Director Director Jun 09 Buy 1.298 10,000 12,980 188,170 06/12/23
Williams Gregg Director Director Apr 27 Buy 1.04 2,040,494 2,122,114 13,677,308 05/01/23
Bolck Joachim Eberhard 10% Owner 10% Owner Jan 03 Buy 0.9 20,000 18,000 2,524,229 04/25/23
Bolck Joachim Eberhard 10% Owner 10% Owner Dec 27 Buy 1.02 30,000 30,600 2,514,229 04/25/23
Bolck Joachim Eberhard 10% Owner 10% Owner Dec 21 Buy 0.95 40,000 38,000 2,504,229 04/25/23
Bolck Joachim Eberhard 10% Owner 10% Owner Dec 19 Buy 0.93 29,000 26,970 2,484,229 04/25/23
Bolck Joachim Eberhard 10% Owner 10% Owner Nov 15 Buy 1.64 2,000 3,280 537,665 04/25/23
Bolck Joachim Eberhard 10% Owner 10% Owner Oct 21 Buy 1.8 26,400 47,520 2,470,229 04/25/23
Bolck Joachim Eberhard 10% Owner 10% Owner Oct 14 Buy 1.76 14,668 25,816 2,457,229 04/25/23
Bolck Joachim Eberhard 10% Owner 10% Owner Sep 12 Buy 3.15 15,568 49,039 2,450,895 04/25/23
Williams Gregg Director Director Jun 13 Buy 2 3,800 7,600 11,237,147 06/15/22
Williams Gregg Director Director Jun 03 Buy 2.4617 3,960 9,748 11,233,347 06/07/22
Williams Gregg Director Director May 31 Buy 2.31 312,493 721,859 11,173,949 06/02/22
Williams Gregg Director Director May 23 Buy 1.98 222,598 440,744 10,916,894 05/25/22
Williams Gregg Director Director May 18 Buy 1.79 803,487 1,438,242 10,694,296 05/20/22